Exome Asset Management LLC

Position in CYTK — Cytokinetics Inc

CIK 2011932 NEW YORK, NY

Position in CYTK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,116,170

-$1,719,883 QoQ

Shares Held

60,056

-42.1% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

3.16%

of 13F equity value

Holder Rank

#162

of 477 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Exome Asset Management LLC holds $110,788,985 across 37 Biotechnology names. CYTK ranks #7 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	27,205	$9,107,961
2	TGTX	Tg Therapeutics, Inc.	164,915	$9,060,430
3	COGT	Cogent Biosciences, Inc.	210,523	$8,147,240
4	IONS	Ionis Pharmaceuticals Inc	88,177	$6,991,554
5	ABVX	Abivax S.A.	46,878	$6,246,962
6	ALMS	Alumis Inc.	204,418	$5,752,322
7	CYTK	Cytokinetics Inc This page	60,056	$5,116,170
8	ELVN	Enliven Therapeutics, Inc.	100,203	$5,085,302

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,116,170	60,056	-42.1%	Shares	Sole	2026-08-14
2026-03-31	$6,836,053	103,718	-16.9%	Shares	Sole	2026-05-15
2025-12-31	$7,926,551	124,749	-12.4%	Shares	Sole	2026-02-13
2025-09-30	$7,827,238	142,417	+23.0%	Shares	Sole	2025-11-14
2025-06-30	$3,826,593	115,817	+11.9%	Shares	Sole	2025-08-15
2025-03-31	$4,158,981	103,483	+57.1%	Shares	Sole	2025-05-16
2024-12-31	$3,099,136	65,883	+12.5%	Shares	Sole	2025-02-14
2024-09-30	$3,093,182	58,583	+125.2%	Shares	Sole	2024-12-13
2024-03-31	$1,823,420	26,008	-25.5%	Shares	Sole	2024-05-15
2023-12-31	$2,914,468	34,908	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.